Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NR1D1 stimulants(Nuclear receptor subfamily 1 group D member 1 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 27 Oct 2023 |